ALLERGAN PLEASANTON
Manufacturer adverse-event records for ALLERGAN PLEASANTON come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2021–2026 · thin-book · quiet Death-code · injury-heavy
Injury-mix signature
ALLERGAN PLEASANTON leans injury-heavy in event_type mix
Injury-coded event_type share is 97.2% (injury-heavy tercile) beside 0.00% Death-coded (quiet). Volume band: thin.
What the Injury-mix reading shows for ALLERGAN PLEASANTON
The standout signal for ALLERGAN PLEASANTON is Injury-mix: 97.2% Injury-coded (injury-heavy) beside 0.00% Death-coded, on a thin-book footprint.
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 3 device types, led in this extract by Injury at 6,975 (97.2% of event_type total). Peak single-year volume reaches 1,898 reports across 6 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (3)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.